BR9809437A - Sais farmaceuticamente aceitáveis de ativos de 3-hidróxi-estr-5(10)-en-17-ona-sulfato como estrogênios - Google Patents

Sais farmaceuticamente aceitáveis de ativos de 3-hidróxi-estr-5(10)-en-17-ona-sulfato como estrogênios

Info

Publication number
BR9809437A
BR9809437A BR9809437-8A BR9809437A BR9809437A BR 9809437 A BR9809437 A BR 9809437A BR 9809437 A BR9809437 A BR 9809437A BR 9809437 A BR9809437 A BR 9809437A
Authority
BR
Brazil
Prior art keywords
hydroxy
pharmaceutically acceptable
sulfate
estr
estrogens
Prior art date
Application number
BR9809437-8A
Other languages
English (en)
Inventor
Michael Z Kagan
Fangming Kong
Leonard Alexander Mcdonald
Panolil Raveendranath
Syed Muzafar Shah
Joseph Zeldis
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Prod filed Critical American Home Prod
Publication of BR9809437A publication Critical patent/BR9809437A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0059—Estrane derivatives substituted in position 17 by a keto group

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Pulmonology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Patente de Invenção:<B>"SAIS FARMACEUTICAMENTE ACEITáVEIS DE ATIVOS DE 3-HIDRóXI-ESTR-5-(10) -EN- 17-ONA SULFATO COMO ESTROGêNIOS"<D>. A presente invenção proporciona um sal farmaceuticamente aceitável de 3-sulfato éster de 3<225>-hidróxi-5(10)-estren-17-ona e um sal farmaceuticamente aceitável de 3-sulfato éster de 3<244>-hidróxi-5(10)-estren-17-ona, os quais são úteis como estrogênios.
BR9809437-8A 1997-05-02 1998-04-28 Sais farmaceuticamente aceitáveis de ativos de 3-hidróxi-estr-5(10)-en-17-ona-sulfato como estrogênios BR9809437A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US85056897A 1997-05-02 1997-05-02
PCT/US1998/008481 WO1998050413A1 (en) 1997-05-02 1998-04-28 Pharmaceutically acceptable salts of 3-hydroxy-estr-5(10)-en-17-one 3-sulphate active as estrogens

Publications (1)

Publication Number Publication Date
BR9809437A true BR9809437A (pt) 2000-06-13

Family

ID=25308509

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9809437-8A BR9809437A (pt) 1997-05-02 1998-04-28 Sais farmaceuticamente aceitáveis de ativos de 3-hidróxi-estr-5(10)-en-17-ona-sulfato como estrogênios

Country Status (15)

Country Link
EP (1) EP0980383B1 (pt)
JP (1) JP2001523266A (pt)
KR (1) KR20010012193A (pt)
CN (1) CN1254341A (pt)
AR (1) AR015375A1 (pt)
AT (1) ATE230413T1 (pt)
AU (1) AU730300B2 (pt)
BR (1) BR9809437A (pt)
CA (1) CA2289008A1 (pt)
DE (1) DE69810461T2 (pt)
DK (1) DK0980383T3 (pt)
ES (1) ES2187963T3 (pt)
HK (1) HK1025336A1 (pt)
WO (1) WO1998050413A1 (pt)
ZA (1) ZA983698B (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL364675A1 (en) * 2001-03-16 2004-12-13 Wyeth Estrogen replacement therapy

Also Published As

Publication number Publication date
EP0980383A1 (en) 2000-02-23
CA2289008A1 (en) 1998-11-12
EP0980383B1 (en) 2003-01-02
ES2187963T3 (es) 2003-06-16
HK1025336A1 (en) 2000-11-10
KR20010012193A (ko) 2001-02-15
DE69810461T2 (de) 2003-10-02
JP2001523266A (ja) 2001-11-20
ZA983698B (en) 1999-11-01
AR015375A1 (es) 2001-05-02
ATE230413T1 (de) 2003-01-15
AU7165598A (en) 1998-11-27
DK0980383T3 (da) 2003-04-14
CN1254341A (zh) 2000-05-24
AU730300B2 (en) 2001-03-01
WO1998050413A1 (en) 1998-11-12
DE69810461D1 (de) 2003-02-06

Similar Documents

Publication Publication Date Title
GB0030716D0 (en) Iodonium salts as latent acid donors
ITTO20000193A0 (it) Sistema di aterectomia rotazionale con punta di taglio a denti di sega.
DE602004011358D1 (de) (4-hydroxyphenyl)-1h-indol-3-carbaldehydoxim-derivative als östrogenagentien
IL178128A0 (en) Salts of 3-0-(3&#39;,3&#39;-dimethyl-succinyl) betulinic acid and pharmaceutical compositions containing the same
BR9902086A (pt) Formulações farmacêuticas.
BR9903984B1 (pt) processo para a produção de uma composição aquosa que contém um peptìdeo farmaceuticamente efetivo.
BR0316670A (pt) Anticorpos quiméricos e humanizados para integrina (alfa)5ß1 que modulam a angiogênese
BR9811948A (pt) Secretores de hormÈnio do crescimento
BR0300709A (pt) Sal de perindopril e as composições farmacêuticas contendo o mesmo
BR0215058A (pt) 2-fenil benzofuranos substituìdos como agentes estrogênicos
BR9909138A (pt) Combinação para o tratamento de dependência de álcool e drogas contendo um antagonista de opióide e um modulador de complexo receptor de nmda
GB9718903D0 (en) Method,compositions and kits for increasing the oral bioavailability of pharmaceutical agents
BR9813817A (pt) Análogos de hemiasterlina
HUP0201038A3 (en) Preparations for the application of anti-inflammatory agents
BR0314716A (pt) Anticorpos de subunidade alfa de lfa-1 e métodos de uso
PT1024809E (pt) Utilizacao de agentes de imunomodulacao
BR9812085A (pt) &#34;método para a sìntese de derivados de quinolina&#34;
BR9713176A (pt) Benzotiofenos amorfos,métodos de preparação e métodos de uso
BR9809437A (pt) Sais farmaceuticamente aceitáveis de ativos de 3-hidróxi-estr-5(10)-en-17-ona-sulfato como estrogênios
BR9814495A (pt) Composto, processo para prepará-lo, uso do mesmo, composição farmacêutica, e, processo
PT1017681E (pt) Derivados de hidrazono-benzazuleno composicoes farmaceuticas e intermediarios
HU9600758D0 (en) Diclofenac composition of diminished gastrointestinal irritation and enhanced biological resorption
BR0017046A (pt) Uso de azóis para prevenção de câncer de pele
BR9911969A (pt) Sal e processos para a preparação de um sal, para a preparação de acetato de n-terc-butilhidroxilamina, para o isolamento de acetato de n-terc- butilhidroxilamina, e para a purificação do acetato de n-terc- butilhidroxilamina
BR9809748A (pt) Estra-5(10), 7-dienos com atividade estrogênica

Legal Events

Date Code Title Description
B25D Requested change of name of applicant approved
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 8A, 9A E 10A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 1971 DE 14/10/2008.